(Q34182136)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

31 July 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Epinephrine is not critical to prevention of hypoglycemia during exercise in humans (English)

1 reference

31 July 2017

1 reference

1 reference

6

Holloszy JO

1 reference

31 July 2017

Hoelzer DR

1

1 reference

31 July 2017

Dalsky GP

2

1 reference

31 July 2017

Schwartz NS

3

1 reference

31 July 2017

Clutter WE

4

1 reference

31 July 2017

Shah SD

5

1 reference

31 July 2017

Cryer PE

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 1986

1 reference

American Journal of Physiology

31 July 2017

published in

1 reference

31 July 2017

volume

251

1 reference

31 July 2017

issue

1 Pt 1

1 reference

31 July 2017

page(s)

E104-10

1 reference

Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epine

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.1.E104

Hormone-fuel interrelationships during fasting

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.1.E104

The role of the adrenergic innervation to the pancreatic islets in the control of insulin release during exercise in man

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.1.E104

Lack of effect of somatostatin on the stimulation of hepatic glycogenolysis by epinephrine in isolated canine hepatocytes

21 January 2018

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Linear increase in aerobic power induced by a strenuous program of endurance exercise

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Fluorescence microscopical and chemical characterization of the adrenergic innervation in mammalian liver tissue

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

The human sympathochromaffin system

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Norepinephrine: hormone and neurotransmitter in man

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

The Effect of Somatostatin on Glucose Uptake and Production by Rat Tissues in Vitro

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Enzymic assay of glycerol, dihydroxyacetone, and glyceraldehyde

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Sympathetic Nervous Activity During Exercise

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Failure of somatostatin to modify effect of glucagon on carbohydrate metabolism in the dog

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion

2 references

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI112279

Immunoassay of insulin with insulin-antibody precipitate

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Role of liver nerves and adrenal medulla in glucose turnover of running rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Determination of free and total insulin and C-peptide in insulin-treated diabetics

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Portal and peripheral vein concentrations of insulin and glucagon after arginine infusion in morbidly obese subjects.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1152/AJPENDO.1986.251.1.E104

Identifiers

DOI

10.1152/AJPENDO.1986.251.1.E104

0 references

Fatcat ID

release_wqr6zubbgzdrzcifms34qserby

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wqr6zubbgzdrzcifms34qserby

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference